CSPAN3 FDA Transparency - Panel 2 - Investors February 7, 2018
Thank you so much for coming. Thank you. I forgot to turn my mike on. Jonathan is a partner with deerfield management and chairman of the deerfield institute. He joined this company in 2013. The company focuses on Venture Capital and structured investments and Bio Technology and pharmaceuticals. Prior to joining deerfield for more than 16 years, jonathan was with Warburg Pincus where he led investment in Bio Technology and pharmaceuticals. Hes been active in policy discussions related to health ...
Source: archive.org